ManageAnticoag vs Know HBV
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ManageAnticoag
This clinical decision support tool assists healthcare professionals in managing patients on oral anticoagulants. It provides guidance on interrupting anticoagulation, managing acute bleeds, and restarting treatment. Clinicians can input patient details to receive individualized advice and access supporting information.
- Periprocedural planning for OAC patients
- Bleed management guidance
- Anticoagulation interruption and bridging advice
- Reversal agent suggestions
- Anticoagulation restart determination
- Quick Reference section for supporting information
Read full descriptionHide full description
This clinical decision support app helps clinicians navigate periprocedural planning and bleed management scenarios for patients on oral anticoagulants (OAC). The app is comprised of three tools to support the following clinical decisions: • Assessing whether and how to interrupt and bridge anticoagulation • Managing acute bleeds, including the suggested use of reversal agents • Determining whether and how anticoagulation should be restarted A clinician can use the app by: • Selecting which tool best applies to the patient scenario and following these steps: o Enter patient details regarding bleed and stroke risk factors as prompted in the selected tool o View individualized guidance on the advice screen o Email a summary of the advice • Use the Quick Reference section to access supporting information and details such as "Guidance for Administering Reversal Agents” and “Components of the Clinician-Patient Discussion." Information in the app is derived from ACC’s Expert Consensus Decision Pathways on Periprocedural Management and Bleed Management in patients with AFib. The information and recommendations in this clinical decision support tool are meant to support clinical decision making. The app is not meant to and should not replace clinical judgement. The healthcare provider is in control of all diagnoses and other clinical decisions.
Know HBV
This educational tool assists primary healthcare professionals in managing adults with chronic hepatitis B. It offers guidance on monitoring and recommends antiviral treatment based on WHO and AASLD guidelines. It is intended for healthcare providers and not for patient self-diagnosis or treatment decisions.
- Chronic hepatitis B monitoring guidance
- Antiviral treatment recommendations
- WHO and AASLD guideline adaptation
- Educational tool for healthcare professionals
- Resource-limited country focus
Read full descriptionHide full description
The chronic hepatitis B Treatment Decision Tool for Adults is developed by the Asian Liver Center at Stanford University in response to the WHO Global Health Sector Strategy on Viral Hepatitis to increase treatment rates when indicated to at least 80% by 2030. The app is an educational tool intended for primary healthcare professionals particularly in resource-limited countries as a general guide in the monitoring of HBsAg positive adults, and when antiviral treatment would be recommended based on the guidelines adapted from the World Health Organization or from the American Association for the Study of Liver Diseases. This app provides general guidance to primary healthcare professionals and is not a substitute for the advice provided by specialists in the management of liver disease and chronic hepatitis. Any course of action recommended or suggested in this educational tool should not be undertaken by the healthcare professional without an evaluation of the patient’s condition and contraindications. The patient should be provided with information about hepatitis B facts, and the potential benefits and risks of antiviral treatment. The app is not intended for use by non-healthcare professionals or patients. Non-healthcare professionals or patients must seek a doctor’s advice in addition to using this app before making any medical decisions.
Screenshots
Verdict
The clearest difference is rating: ManageAnticoag at 4.9 against Know HBV's 4.3. Know HBV's advantage is update cadence (every 4 months vs every 23 months). On price, review sentiment, ratings volume and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
ManageAnticoag holds the better App Store score, 4.9 against 4.3. Both are backed by a comparable volume of ratings — 7 and 3 respectively. Written reviews split almost evenly too, at 100% and 100% positive.
ManageAnticoag ships an update every 23 months, Know HBV every 4 months. The most recent releases landed on November 18, 2026 and November 16, 2026 respectively.
| Parameter | ManageAnticoag | Know HBV |
|---|---|---|
| Price | Free | Free |
| Rating | 4.9 (7 ratings) — better | 4.3 (3 ratings) |
| Positive reviews | 100.0% of reviews | 100.0% of reviews |
| Number of ratings | 7 — better | 3 |
| Update frequency | Every 23 months | Every 4 months — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 | 12.0 — better |
| Further details — not scored | ||
| Size | 34 MB | 67 MB |
| Age rating | 17+ | 17+ |
| Developer | American College of Cardiology | Hep B Moms |
Customer experience
ManageAnticoag
Know HBV
In-app purchases
ManageAnticoag
No in-app purchases
Know HBV
No in-app purchases









